These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
486 related articles for article (PubMed ID: 22127234)
1. Autophagy positively regulates the CD44(+) CD24(-/low) breast cancer stem-like phenotype. Cufí S; Vazquez-Martin A; Oliveras-Ferraros C; Martin-Castillo B; Vellon L; Menendez JA Cell Cycle; 2011 Nov; 10(22):3871-85. PubMed ID: 22127234 [TBL] [Abstract][Full Text] [Related]
2. Nuclear beta-catenin and CD44 upregulation characterize invasive cell populations in non-aggressive MCF-7 breast cancer cells. Uchino M; Kojima H; Wada K; Imada M; Onoda F; Satofuka H; Utsugi T; Murakami Y BMC Cancer; 2010 Aug; 10():414. PubMed ID: 20696077 [TBL] [Abstract][Full Text] [Related]
3. Differentiation of breast cancer stem cells by knockdown of CD44: promising differentiation therapy. Pham PV; Phan NL; Nguyen NT; Truong NH; Duong TT; Le DV; Truong KD; Phan NK J Transl Med; 2011 Dec; 9():209. PubMed ID: 22152097 [TBL] [Abstract][Full Text] [Related]
4. SLUG/SNAI2 and tumor necrosis factor generate breast cells with CD44+/CD24- phenotype. Bhat-Nakshatri P; Appaiah H; Ballas C; Pick-Franke P; Goulet R; Badve S; Srour EF; Nakshatri H BMC Cancer; 2010 Aug; 10():411. PubMed ID: 20691079 [TBL] [Abstract][Full Text] [Related]
5. Re-expression of miR-21 contributes to migration and invasion by inducing epithelial-mesenchymal transition consistent with cancer stem cell characteristics in MCF-7 cells. Han M; Liu M; Wang Y; Mo Z; Bi X; Liu Z; Fan Y; Chen X; Wu C Mol Cell Biochem; 2012 Apr; 363(1-2):427-36. PubMed ID: 22187223 [TBL] [Abstract][Full Text] [Related]
6. Metformin regulates breast cancer stem cell ontogeny by transcriptional regulation of the epithelial-mesenchymal transition (EMT) status. Vazquez-Martin A; Oliveras-Ferraros C; Cufí S; Del Barco S; Martin-Castillo B; Menendez JA Cell Cycle; 2010 Sep; 9(18):3807-14. PubMed ID: 20890129 [TBL] [Abstract][Full Text] [Related]
7. Twist modulates breast cancer stem cells by transcriptional regulation of CD24 expression. Vesuna F; Lisok A; Kimble B; Raman V Neoplasia; 2009 Dec; 11(12):1318-28. PubMed ID: 20019840 [TBL] [Abstract][Full Text] [Related]
9. STAT3 as a promising chemoresistance biomarker associated with the CD44 Moreira MP; da Conceição Braga L; Cassali GD; Silva LM Exp Cell Res; 2018 Feb; 363(2):283-290. PubMed ID: 29352988 [TBL] [Abstract][Full Text] [Related]
10. CD44 and CD24 coordinate the reprogramming of nasopharyngeal carcinoma cells towards a cancer stem cell phenotype through STAT3 activation. Shen YA; Wang CY; Chuang HY; Hwang JJ; Chi WH; Shu CH; Ho CY; Li WY; Chen YJ Oncotarget; 2016 Sep; 7(36):58351-58366. PubMed ID: 27521216 [TBL] [Abstract][Full Text] [Related]
11. HER2-associated radioresistance of breast cancer stem cells isolated from HER2-negative breast cancer cells. Duru N; Fan M; Candas D; Menaa C; Liu HC; Nantajit D; Wen Y; Xiao K; Eldridge A; Chromy BA; Li S; Spitz DR; Lam KS; Wicha MS; Li JJ Clin Cancer Res; 2012 Dec; 18(24):6634-47. PubMed ID: 23091114 [TBL] [Abstract][Full Text] [Related]
12. Inhibition of Cdk2 kinase activity selectively targets the CD44⁺/CD24⁻/Low stem-like subpopulation and restores chemosensitivity of SUM149PT triple-negative breast cancer cells. Opyrchal M; Salisbury JL; Iankov I; Goetz MP; McCubrey J; Gambino MW; Malatino L; Puccia G; Ingle JN; Galanis E; D'Assoro AB Int J Oncol; 2014 Sep; 45(3):1193-9. PubMed ID: 24970653 [TBL] [Abstract][Full Text] [Related]
13. Autophagy of cancer stem cells is involved with chemoresistance of colon cancer cells. Wu S; Wang X; Chen J; Chen Y Biochem Biophys Res Commun; 2013 May; 434(4):898-903. PubMed ID: 23624503 [TBL] [Abstract][Full Text] [Related]
14. A novel oncogenic role of inositol phosphatase SHIP2 in ER-negative breast cancer stem cells: involvement of JNK/vimentin activation. Fu CH; Lin RJ; Yu J; Chang WW; Liao GS; Chang WY; Tseng LM; Tsai YF; Yu JC; Yu AL Stem Cells; 2014 Aug; 32(8):2048-60. PubMed ID: 24802135 [TBL] [Abstract][Full Text] [Related]
15. TGFβ1 Promotes Breast Cancer Local Invasion and Liver Metastasis by Increasing the CD44 Zhang C; Gao H; Li C; Tu J; Chen Z; Su W; Geng X; Chen X; Wang J; Pan W Technol Cancer Res Treat; 2018 Jan; 17():1533033818764497. PubMed ID: 29658391 [TBL] [Abstract][Full Text] [Related]
16. Dynamic emergence of the mesenchymal CD44(pos)CD24(neg/low) phenotype in HER2-gene amplified breast cancer cells with de novo resistance to trastuzumab (Herceptin). Oliveras-Ferraros C; Vazquez-Martin A; Martin-Castillo B; Cufí S; Del Barco S; Lopez-Bonet E; Brunet J; Menendez JA Biochem Biophys Res Commun; 2010 Jun; 397(1):27-33. PubMed ID: 20470755 [TBL] [Abstract][Full Text] [Related]
17. Prolonged drug selection of breast cancer cells and enrichment of cancer stem cell characteristics. Calcagno AM; Salcido CD; Gillet JP; Wu CP; Fostel JM; Mumau MD; Gottesman MM; Varticovski L; Ambudkar SV J Natl Cancer Inst; 2010 Nov; 102(21):1637-52. PubMed ID: 20935265 [TBL] [Abstract][Full Text] [Related]
18. Metformin-induced preferential killing of breast cancer initiating CD44+CD24-/low cells is sufficient to overcome primary resistance to trastuzumab in HER2+ human breast cancer xenografts. Cufi S; Corominas-Faja B; Vazquez-Martin A; Oliveras-Ferraros C; Dorca J; Bosch-Barrera J; Martin-Castillo B; Menendez JA Oncotarget; 2012 Apr; 3(4):395-8. PubMed ID: 22565037 [TBL] [Abstract][Full Text] [Related]
19. BRCA1-IRIS overexpression promotes and maintains the tumor initiating phenotype: implications for triple negative breast cancer early lesions. Sinha A; Paul BT; Sullivan LM; Sims H; El Bastawisy A; Yousef HF; Zekri AN; Bahnassy AA; ElShamy WM Oncotarget; 2017 Feb; 8(6):10114-10135. PubMed ID: 28052035 [TBL] [Abstract][Full Text] [Related]
20. ALDH1 is a better clinical indicator for relapse of invasive ductal breast cancer than the CD44+/CD24- phenotype. Zhong Y; Shen S; Zhou Y; Mao F; Guan J; Lin Y; Xu Y; Sun Q Med Oncol; 2014 Mar; 31(3):864. PubMed ID: 24519209 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]